A Highly Efficient Method for the Site-specific Integration of Transfected Plasmids into the Genome of Mammalian Cells Using Purified Retroviral Integrase
Overview
Authors
Affiliations
Using purified bovine leukemia virus (BLV) integrase with liposome, we developed a highly efficient method for the site-specific integration of plasmid vectors into the genome of cultured mammalian cells. The presence of the BLV integrase recognition sequence (IRS) in both the host genome and the plasmid vector to be transfected was required for this integration. The integration occurred within the IRS pre-introduced into the host genome and resulted in a complete or partial deletion of the sequence and an adjacent drug-resistant gene. This site-specific integration was not observed upon transfection without the integrase or with vectors harboring no IRS. This novel method may be useful for manipulating a mammalian genome or for targeting a retroviral genome integrated into a virus-infected cell by using the virus-specific integrase and LTR sequence.
Current advances in retroviral gene therapy.
Yi Y, Noh M, Lee K Curr Gene Ther. 2011; 11(3):218-28.
PMID: 21453283 PMC: 3182074. DOI: 10.2174/156652311795684740.
Nonviral gene delivery: principle, limitations, and recent progress.
Al-Dosari M, Gao X AAPS J. 2009; 11(4):671-81.
PMID: 19834816 PMC: 2782077. DOI: 10.1208/s12248-009-9143-y.
Gillet N, Florins A, Boxus M, Burteau C, Nigro A, Vandermeers F Retrovirology. 2007; 4:18.
PMID: 17362524 PMC: 1839114. DOI: 10.1186/1742-4690-4-18.
Copeland C, Mann V, Brindley P Mol Genet Genomics. 2006; 277(2):161-70.
PMID: 17131159 DOI: 10.1007/s00438-006-0181-1.